A Phase 2 interventional study of Laminaria tent and Laminaria plus Misoprostol in Cervical Spasm, sponsored by Zagazig University. Status unknown at 1 site in Egypt. Open to female participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-12-07.
Sponsored by Zagazig University · Phase 2, Interventional, and Treatment
Laminaria and Misoprostol before Operative Hysteroscopy
The use of laminaria versus laminaria plus misoprostol was compared before operative hysteroscopy in nulliparous women to assess the efficacy of both methods in cervical dilatation.
123 studies on the registry are indexed under Spasm; 7 are open to participants now.
This study's planned enrollment of 100 is above the median of 80 across 104 interventional studies indexed under Spasm.
Browse Spasm studies →Zagazig University is the lead sponsor of 459 studies on the registry; 77 are open to participants now.
Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Inclusion Criteria: nullipara
Exclusion Criteria: previous pregnancy
cervical lesion
to misoprostol
-
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Laminaria tent was introduced in the cervical canal
Device: Laminaria tent
Laminaria and Misoprostol were introduced
Drug: Laminaria plus Misoprostol
Laminaria tent was inserted for 12 hours before Hysteroscopy
Laminaria plus Misoprostol were inserted for 12 hours before Hysteroscopy
Also known as: cytotec,
Preoperative cervical width
cervical width in Hegar dilators number
Time frame: 12 hours
adverse effects
adverse effects of the method used or hysteroscopy
Time frame: 24 hours
Plan to share: Undecided
No publications or documents are linked to this record.
This study is status unknown, as verified in Dec 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.